The novel thioredoxin reductase inhibitor butaselen suppresses lung cancer by inducing oxidative stress
<p>Lung cancer is one of the leading causes of cancer-related deaths worldwide with limited treatment options available. The anti-tumor effects of the TrxR inhibitor Butaselen (BS/BS1801) on lung cancer and its underlying mechanisms remain unknown.</p> <p>This study utilized lung c...
محفوظ في:
| المؤلف الرئيسي: | Yifan Chen (446592) (author) |
|---|---|
| مؤلفون آخرون: | Guangliang Qiang (296666) (author), Liang Jin (316008) (author), Yan Sun (22436) (author), Guozhou Zhang (22688355) (author), Fengling Hu (3595472) (author), Jinhui Feng (269301) (author), Feng Wei (426184) (author), Shengxin Zeng (22688358) (author), Lixiang Xue (23235) (author), Huihui Zeng (6700337) (author), Shaohua Ma (8746758) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
The E3 ligase Tripartite motif 7 drives the progression of non-alcoholic fatty liver disease by targeting DUSP10 degradation
حسب: Feng-Juan Yan (21454759)
منشور في: (2025) -
Supplementary Figure S1 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
حسب: Rumani Singh (17141575)
منشور في: (2025) -
Supplementary Figure S2 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
حسب: Rumani Singh (17141575)
منشور في: (2025) -
Supplementary Figure S3 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
حسب: Rumani Singh (17141575)
منشور في: (2025) -
Supplementary Figure S4 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
حسب: Rumani Singh (17141575)
منشور في: (2025)